Evaluation of data quality of malignant tumor registration in Xigang District of Dalian City from 2005 to 2016
LIU Dan1 TIAN Jian-chi1 LI Xiao-dong2▲
1.Dalian Xigang District Centre for Disease Control and Prevention, Liaoning Province, Dalian 116011, China;
2.Dalian Medical University, Institute of Cancer Stem Cell, Liaoning Province, Dalian 116044, China
Objective To evaluate the data of the malignant tumor registration report from January 2005 to December 2016 in Xigang District of Dalian City in the aspects of data reliability and registration completeness, so as to provide a basis for further improving the quality of tumor registration.Methods All morbidity and mortality cases diagnosed as malignant tumors in Xigang District of Dalian City from January 2005 to December 2016 were exported from Dalian Cancer Registration Report Management System.Through SAS programming, the data were merged, deduplicated, summarized and analyzed, and statistical charts were generated.Results The proportion of histopathology (MV%) in Xigang District from January 2005 to December 2016 was 72.88%, cases with death certificate notification (DCN) accounted for 18.78%, and cases with death certificate only (DCO) accounted for 2.85%.There was still a certain gap from the national standard of <15%.The ratio of the number of deaths to the number of new cases (M/I) was 0.41, which did not reach the standard of 0.6-0.8.The percentage of new cases of malignant tumors registered in the same period, with other unspecified sites and unknown primary sites (secondary) (O&U%) was 3.13.Conclusion The MV% in Xigang District from January 2005 to December 2016 is higher than the national standard.However, the number of DCN cases has been in an increasing trend in recent years, reaching 35.54% in 2016.M/I is 0.41, less than the standard of 0.6-0.8, which is related to the high incidence rate of thyroid cancer, breast cancer and other tumors with good prognosis in Dalian City.The O&U% is 3.13%, but increases to 4.24% in 2016.In recent years, it has been gradually increasing, but the overall level is not high.In general,the reliability of tumor registration data in Xigang District of Dalian City is relatively high, but the completeness is not high, so it needs to be strengthened urgently.
刘 丹；田健池；李晓东. 大连市西岗区2005～2016年恶性肿瘤登记数据质量评价[J]. 中国当代医药, 2020, 27(20): 183-187.
LIU Dan1 TIAN Jian-chi1 LI Xiao-dong2▲. Evaluation of data quality of malignant tumor registration in Xigang District of Dalian City from 2005 to 2016. 中国当代医药, 2020, 27(20): 183-187.
Curado MP，Voti L，Sortino-Rachou AM.Cancer registration data and quality indicators in low and middle income countries：their interpretation and potential use for the improvement of cancer care[J].Cancer Causes Control，2009，20（5）：751-756.
[17]
Gammelager H，Christiansen CF，Johansen MB，et al.Quality of urological cancer diagnoses in the Danish National Registry of Patients[J].Eur J Cancer Prev，2012，21（6）：545-551.
[18]
Moore MA.Overview of cancer registration research in the Asian Pacific from 2008-2013[J].Asian Pac J Cancer Prev，2013，14（8）：4461-4484.
[19]
Pearce N，Blair A，Vineis P，et al.IARC monographs：40 years of evaluating carcinogenic hazards to humans[J].Environ Health Perspect，2015，123（6）：507-514.
[20]
Rashbass J，Peake M.The evolution of cancer registration[J].Eur J Cancer Care （Engl），2014，23（6）：757-759.
[21]
Crocker-Buque T，Pollock AM.Appraising the quality of sub-Saharan African cancer registration systems that contributed to GLOBOCAN 2008：a review of the literature and critical appraisal[J].J R Soc Med，2015，108（2）：57-67.
[22]
Dehler S，Tonev S，Korol D，et al.Recent trends in cancer incidence：impact of risk factors，diagnostic activities and data quality of registration[J].Tumori，2014，100（4）：399-405.
[23]
Wei KR，Chen WQ，Zhang SW，et al.Cancer registration in the Peoples Republic of China[J].Asian Pac J Cancer Prev，2012，13（8）：4209-4214.
京公网安备 11010502046607号